Immortalization of primary epithelial cells by E1A 12S requires late, second exon-encoded functions in addition to complex formation with pRB and p300

Cell Growth and Differentiation

Volumn 8, Issue 5, 1997, Pages 541-551

  Gopalakrishnan, Shobha ^a,b   Douglas, Janet L ^a,c   Quinlan, Margaret P ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL IMMORTALIZATION; CELL PROLIFERATION; EPITHELIUM CELL; EXON; EXPRESSION VECTOR; GENE MUTATION; GROWTH REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOVIRUS E1A PROTEINS; ANIMALS; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; E1A-ASSOCIATED P300 PROTEIN; EPITHELIUM; EXONS; GENE EXPRESSION REGULATION, VIRAL; NUCLEAR PROTEINS; RATS; RETINOBLASTOMA PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

ADENOVIRIDAE; ANIMALIA;

EID: 0030955636     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Hayflick, L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res., 37: 614-636, 1965.
2. Newbold, R. F., Overell, R. W., and Connell, J. R. Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens. Nature (Lond.), 299: 633-635, 1982.
3. Bols, B. L M., Naaktgeboren, J. M., and Simons, J. W. I. M. Immortalization of Syrian hamster embryo cells is in itself a multistep event. Cancer Res., 51: 1177-1184, 1991.
4. Cerni, C., Binetruy, B., Schiller, J. T., Lowy, D. R., Meneguzzi, G., and Cuzin, F. Successive steps in the process of immortalization identified by transfer of separate bovine papillomavirus genes. Proc. Natl. Acad. Sci. USA, 86: 3266-3270, 1989.
5. Shay, J. W., Wright, W. E., and Werbin, H. Defining the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta, 1072: 1-7, 1991.
6. Bayley, S. T., and Mymryk, J. S. Adenovirus E1A proteins and transformation. Int. J. Oncol., 5: 325-444, 1994.
7. Quinlan, M. P. E1A 12S in the absence of E1B or other cooperating oncogenes enables cells to overcome apoptosis. Oncogene, 8: 3289-3296, 1993.
8. Houweling, A., van der Elsen, P. J., and Van der Eb, A. J. Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA. Virology, 105: 537-550, 1980.
9. Bellett, A. J. D., Li, P., David, E. T., Mackey, E. J., Braithwaite, A. W., and Cutt, J. R. Control functions of adenovirus transformation region E1A products in rat and human cells. Mol. Cell. Biol., 5: 1933-1939, 1985.
10. Kaczmarek, L., Ferguson, B., Rosenberg, M., and Baserga, R. Induction of cellular DNA synthesis by purified adenovirus E1A proteins. Virology, 152: 1-10, 1986.
11. Quinlan, M. P., and Grodzicker, T. Adenovirus E1A 12S protein induces DNA synthesis and proliferation in primary epithelial cells in both the presence and absence of serum. J. Virol., 61: 673-682, 1987.
12. Quinlan, M. P., and Douglas, J. L. Immortalization of primary epithelial cells requires first and second exon functions of Ad5 12S. J. Virol., 66: 2020-2030, 1992.
13. Quinlan, M. P. Enhanced proliferation, growth factor induction and immortalization by adenovirus E1A 12S in the absence of E1B. Oncogene, 9: 2639-2647, 1994.
14. Shimojo, H., and Yamashita, T. Induction of DNA synthesis by adenovirus in contact-inhibited hamster cells. Virology, 36: 422-433, 1968.
15. Stabel, S., Argos, P., and Philipson, L. The release of growth arrest by microinjection of adenovirus E1A DNA. EMBO J., 4: 2329-2336, 1985.
16. Graham, F. L, Abrahams, P. J., Mulder, C., Heijneker, H. L., Warnaar, S. O., deVries, F. A. J., Fiers, W., and Van der Eb, A. J. Studies on in vitro transformation by DNA and DNA fragments of human adenovirus and simian virus 40. Cold Spring Harbor Symp. Quant. Biol., 39: 637-650, 1974.
17. Ruley, H. E. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature (Lond.), 304: 602-606, 1983.
18. Quinlan, M. P., Whyte, P., and Grodzicker, T. Growth factor induction by the adenovirus type 5 E1A 12S protein is required for immortalization of primary epithelial cells. Mol. Cell. Biol., 8: 3191-3203, 1988.
19. Douglas, J. L., and Quinlan, M. P. Efficient nuclear localization of the Ad5 E1A 12S protein is necessary for immortalization but not cotransformation of primary epithelial cells. Cell Growth & Differ., 5: 475-483, 1994.
20. Bellett, A. J. D., Jackson, P., David, E. T., Bennett, E. J., and Cronin, B. Functions of the two adenovirus early E1A proteins and their conserved domains in cell cycle alteration, actin reorganization, and gene activation in rat cells. J. Virol., 63: 303-310, 1989.
21. Lillie, J. W., Loewenstein, P. M., Green, M. R., and Green, M. Functional domains of adenovirus type 5 E1a proteins. Cell, 50: 1091-1100, 1987.
22. Smith, D. H., and Ziff, E. B. The amino-terminal region of the adenovirus serotype 5 E1a protein performs two separate functions when expressed in primary baby rat kidney cells. Mol. Cell. Biol., 8: 3882-3890, 1988.
23. Subramanian, T., La Regina, M., and Chinnadurai, G. Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein. Oncogene, 4: 415-420, 1989.
24. Zerler, B., Roberts, R. J., Mathews, M. B., and Moran, E. Different functional domains of the adenovirus E1A gene are involved in regulation of host cell cycle products. Mol. Cell. Biol., 7: 821-829, 1987.
25. Kimelman, L., Ferguson, B., Rosenberg, M., and Roberts, B. E. E1A regions of the human adenoviruses and the highly oncogenic simian virus 7 are closely related. J. Virol., 53: 399-409, 1985.
26. van Ormondt, H., Maat, J., and Dijkema, R. Comparison of nucleotide sequences of the early E1a regions for subgroups A, B and C of human adenoviruses. Gene (Amst.), 12: 63-76, 1980.
27. Schneider, J. F., Fisher, F., Goding, C. R., and Jones, N. C. Mutational analysis of the adenovirus E1a gene: the role of transcriptional regulation in transformation. EMBO J., 6: 2053-2060, 1987.
28. Whyte, P., Ruley, H. E., and Harlow, E. Two regions of the adenovirus early region 1A proteins are required for transformation. J. Virol., 62: 257-265, 1988.
29. Ferguson, B., Krippl, B., Andrisani, O., Jones, N., and Westphal, H. E1A 13S and 12S mRNA products made in Escherichia coli both function as nucleus-localized transcription activators but do not directly bind DNA. Mol. Cell. Biol., 5: 2653-2661, 1985.
30. Harlow, E., Whyte, P., and Franza, B. R., Jr. Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol. Cell. Biol., 6: 1579-1589, 1986.
31. Yee, S., and Branton, P. E. Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptides. Virology, 147: 142-153, 1985.
32. Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., and Harlow, E. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (Lond.), 334: 124-129, 1988.
33. Ewen, M. E., Xing, Y., Bentley, L. J., and Livingston, D. M. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell, 66: 1155-1164, 1991.
34. Li, Y., Graham, C., Lacy, S., Duncan, A. M. V., and Whyte, P. The adenovirus E1A-associated 130 KD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev., 7: 2366-2377, 1993.
35. Pines, J., and Hunter, T. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature (Lond.), 346: 760-763, 1990.
36. Eckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B., and Livingston, D. M. Molecular cloning and functional analysis of the adenovirus E1A-associated 300 kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev., 8: 869-884, 1994.
37. Wang, H-G. H., Rikitake, Y., Carter, M. C., Yaciuk, P., Abraham, S. E., Zerler, B., and Moran, E. Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Viral., 67: 476-488, 1993.
38. Dyson, N., Guida, P., McCall, C., and Harlow, E. Adenovirus E1A makes two distinct contacts with the retinoblastoma protein. J. Virol., 66: 4606-4611, 1992.
39. Giordano, A., McCall, C., Whyte, P., and Franza, B. R., Jr. Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product. Oncogene, 6: 481-485, 1991.
40. Howe, J. A., and Bayley, S. T. Effects of Ad5 E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastoma protein and cyclin A. Virology, 186: 15-24, 1992.
41. Whyte, P., Williamson, N. M., and Harlow, E. Cellular targets for transformation by the adenovirus E1A proteins. Cell, 56: 67-75, 1989.
42. Dyson, N., Buchkovich, K., Whyte, P., and Harlow, E. The cellular 107 K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 virus. Cell, 58: 249-255, 1989.
43. Dyson, N., Howley, P. M., Munger, K., and Harlow, E. The human papillomavirus type 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (Washington DC), 243: 934-937, 1989.
44. Dyson, N., Bernards, R., Friend, S. H., Gooding, L. R., Hassell, J. A., Major, E. O., Pipas, J. M., Vandyke, T., and Harlow, E. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J. Virol., 64: 1353-1356, 1990.
45. Dyson, N., Guida, P., Munger, K., and Harlow, E. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J. Virol., 66: 6893-6902, 1992.
46. DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J., Huang, C., Lee, W., Marsilio, E., Paucha, E., and Livingston, D. M. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell, 54: 275-283, 1988.
47. Larose, A., Dyson, N., Sullivan, M., Harlow, E., and Bastin, M. Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization. J. Virol., 65: 2308-2313, 1991.
48. Goutebroze, L., de La Roche Saint André, C., Scherneck, S., and Feunteun, J. Mutations within the hamster polyomavirus large T antigen domain involved in pRb binding impair virus productive cycle and immortalization capacity. Oncogene, 8: 685-693, 1993.
49. Rotter, V., Foord, O., and Navot, N. In search of the functions of normal p53 protein. Trends Cell. Biol., 3: 46-49, 1993.
50. Ullrich, S. J., Anderson, C. W., Mercer, W. E., and Appella, E. The p53 tumor suppressor protein, a modulator of cell proliferation. J. Biol. Chem., 267: 15259-15262, 1992.
51. Lowe, S. W., and Ruley, H. E. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev., 7: 535-545, 1993.
52. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L, Kimchi, A., and Oren, M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 353: 345-347, 1991.
53. Yew, P. R., and Berk, A. J. Inhibition of p53 transactivation required for transformation by adenovirus early 16 protein. Nature (Lond.), 357: 82-85, 1992.
54. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. VVAF1: a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
55. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 CDK-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
56. Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., and Smith, J. R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression system. Exp. Cell Res., 211: 90-98, 1994.
57. Shen, Y., and Shenk, T. Relief of p53-mediated transcriptional repression by the adenovirus E1B 19 kDa protein or the cellular Bcl-2 protein. Proc. Natl. Acad. Sci. USA, 91: 8940-8944, 1994.
58. Harvey, D. M., and Levine, A. J. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev., 5: 2375-2385, 1991.
59. Ulrich, E., Boehmelt, G., Bird, A., and Beug, H. Immortalization of conditionally transformed chicken cells: loss of normal p53 expression is an early step that is independent of cell transformation. Genes Dev., 6: 876-887, 1992.
60. Douglas, J. L., Gopalakrishnan, S., and Quinlan, M. P. Modulation of transformation of primary epithelial cells by the second exon of the Ad5 E1A 12S gene. Oncogene, 6: 2093-2103, 1991.
61. Jones, N., and Shenk, T. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell, 17: 683-689, 1979.
62. Harlow, E., Franza, B., and Schley, C. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. J. Viral., 55: 533-546, 1985.
63. Wang, H-G. H., Draetta, G., and Moran, E. E1A induces phosphorylation of the retinoblastoma protein independently of direct physical association between the E1A and retinoblastoma products. Mol. Cell. Biol., 11: 4253-4265, 1991.
64. Hollingsworth, R. E., Jr., Chen, P., and Lee, W. Integration of cell cycle control with transcriptional regulation by the retinoblastoma protein. Curr. Opin. Cell Biol., 5: 194-200, 1993.
65. Van Doren, K., and Gluzman, Y. Efficient transformation of human fibroblasts by adenovirus-simian virus 40 recombinants. Mol. Cell. Biol., 4: 1653-1656, 1984.
66. Quinlan, M. P. Expression of antisense E1A in 293 cells results in altered cell morphologies and cessation of proliferation. Oncogene, 8: 257-265, 1993.
67. Chen, S., and Paucha, E. Identification of a region of simian virus 40 large T antigen required for cell transformation. J. Virol., 64: 3350-3357, 1990.
68. Christensen, J. B., and Imperiale, M. J. Inactivation of the retinoblastoma susceptibility protein is not sufficient for the transforming function of the conserved region 2-like domain of simian virus 40 large T antigen. J. Virol., 65: 3945-3948, 1995.
69. Manfredi, J. J., and Prives, C. Binding of p53 and p105-RB is not sufficient for oncogenic transformation by a hybrid polyomavirus-simian virus 40 large T antigen. J. Virol., 64: 5250-5259, 1990.
70. Missero, C., Calautti, E., Eckner, R., Chin, J., Tsai, L. H., Livingston, D. M., and Dotto, G. P. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA, 92: 5451-5455, 1995.
71. Sanchez-Prieto, R., Lleonart, M., and Ramon y Cajal, S. Lack of correlation between p53 protein level and sensitivity to DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants. Oncogene, 11: 675-682, 1995.
72. Soddu, S., Blandino, G., Scardigli, R., Martinelli, R., Rizzo, M. G., Crescenzi, M., and Sacchi, A. Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes. Mol. Cell. Biol., 16: 487-495, 1996.
73. Teodora, J. G., Shore, G. C., and Branton, P. E. Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms. Oncogene, 11: 467-474, 1995.
74. Momand, J., Zambatti, G. P., Olson, D. C., George, D., and Levine, A. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated trans-activation. Cell, 69: 1237-1245, 1992.
75. Boyd, J. M., Subramanian, T., Schaeper, U., La Regina, M., Bayley, S., and Chinnadurai, G. A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J., 12: 469-478, 1993.
76. Pines, J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J., 308: 697-711, 1995.
77. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
78. Taub, M., Chuman, L., Saier, M. N., and Sato, G. Growth of Madin-Darby canine kidney epithelial cell (MDCK) line in hormone-supplemented, serum-free medium. Proc. Natl. Acad. Sci. USA, 76: 3338-3342, 1979.
79. Laemmli, U. K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.